Most Read Articles
Rachel Soon, 26 Jun 2018

MIMS Pharmacist presents an overview of phosphatidylcholine's physiological role, as well as contemporary research on its pharmacology and effects.

30 Nov 2017
Fluarex Tetra - Inactivated quadrivalent influenza vaccine (split virion) vaccine (inj) 0.5 mL - GlaxoSmithKline
17 Apr 2018
Antiandrogens, insulin sensitizers and oestrogen-progestin oral contraceptive pills (OCPs) are all effective in the treatment of hirsutism, suggest the results of a systematic review and meta-analysis.
Ms Penny Wong Pei Nee, 3 days ago
Antibiotics, also known as antibacterials, are a group of medications that either destroy the infecting bacteria or slow down their growth.

R2CHOP reduces CNS relapse in diffuse large B-cell lymphoma

5 days ago
Kanker darah, seperti leukemia, Hodgkin lymphona, non-Hodgkin lymphoma dan multiple myeloma

Adding lenalidomide to the R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; R2CHOP) frontline therapy for diffuse large B-cell lymphoma (DLBCL) reduces the rate of central nervous system (CNS) relapse, according to a recent study.

Accessing records from two R2CHOP trials, researchers grouped 136 DLBCL patients into three groups of low (n=14; median age 56.5 years), intermediate (n=97; median age 69 years) and high (n=25; median age 69 years) risk of CNS relapse. The Kaplan-Meier method was used to estimate relapse rates, which were then compared among groups.

Only one of the participants developed isolated CNS relapse, yielding an incidence rate of 0.7 percent. The time to relapse was 10 months and the event occurred 6 months after a complete treatment response was achieved. The participant belonged to the high-risk group.

The Kaplan-Meier estimate for the 2-year relapse rate was 0.9 percent for the entire R2CHOP cohort. The corresponding values for the low-, intermediate- and high-risk groups were 0, 0 and 5.0 percent. Compared with database patients treated with R-CHOP only, the 2-year CNS relapse rate for R2CHOP was lower (0.9 percent vs 1.8 percent).

The same was true for the low- (0 percent vs 1.4 percent) and intermediate- (0 percent vs 2.2 percent) risk groups, but not the high-risk patients (5.0 percent vs 1.1 percent).

The findings support further studies on the value of lenalidomide in decreasing CNS relapse in DLBCL patients, said researchers, noting that involving clinical and molecular factors in patient risk stratification may be an effective approach.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 26 Jun 2018

MIMS Pharmacist presents an overview of phosphatidylcholine's physiological role, as well as contemporary research on its pharmacology and effects.

30 Nov 2017
Fluarex Tetra - Inactivated quadrivalent influenza vaccine (split virion) vaccine (inj) 0.5 mL - GlaxoSmithKline
17 Apr 2018
Antiandrogens, insulin sensitizers and oestrogen-progestin oral contraceptive pills (OCPs) are all effective in the treatment of hirsutism, suggest the results of a systematic review and meta-analysis.
Ms Penny Wong Pei Nee, 3 days ago
Antibiotics, also known as antibacterials, are a group of medications that either destroy the infecting bacteria or slow down their growth.